THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Yıl: 2022 Cilt: 25 Sayı: 2 Sayfa Aralığı: 262 - 273 Metin Dili: İngilizce DOI: 10.31086/tjgeri.2022.284 İndeks Tarihi: 12-05-2023
THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA
Öz: Introduction: This study aimed to investigate the relationship between community-acquired pneumonia severity and D-dimer levels in individuals older than 65. We also investigated the relationship between D-dimer levels and the adverse outcomes in patients with community-acquired pneumonia after excluding all other potential causes of high D-dimer levels. Materials and Methods: Patients older than 65 who were admitted to the emergency service of a tertiary chest diseases training and research hospital between January 1, 2019, and October 1, 2020, were evaluated. Patients who met the diagnostic criteria for community-acquired pneumonia were included. In clinically questionable cases of coexistence of pulmonary embolism and community-acquired pneumonia, D-dimer levels and pulmonary computerize tomography angiography or ventilation-perfusion scintigraphy were examined. Confirmed pulmonary embolism patients were excluded. Of 4,608 patients evaluated, 82 had a diagnosis of community-acquired pneumonia with no comorbidity. The severity of these cases was determined with the CURB-65 score and pneumonia severity index score. Results: The mean age of the cases was 73.83±6.67 years, while their gender was predominantly male (n=51, 62.2%). A statistically significant correlation was found between D-dimer levels and both the CURB-65 and pneumonia severity index high-risk groups (p=0.001 and p=0.001, respectively). The adverse outcomes were statistically higher in both the CURB-65 and pneumonia severity index high-risk groups (p<0.001). Conclusions: D-Dimer is an easy-to-interpret, fast, inexpensive, highly sensitive, and simple test widely used in clinics. We found that high levels of D-dimer can predict the need for intensive care unit care, disease severity, and mortality of elderly community-acquired pneumonia patients.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Wunderink RG, Waterer GW. Clinical practice. Community-acquired pneumonia. N Engl J Med. 2014;370(6):543-51. (PMID: 24499212)
- 2. C. Troeger, M. Forouzanfar, P.C. Rao, et al. GBD 2015 LRI Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Dis ease Study 2015. Lancet Infect Dis. 2017;(11):1133-61. (PMID: 28843578)
- 3. Donowitz GR, Cox HL. Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med. 2007;23(3):515-34, (PMID: 17631231)
- 4. Yu H, Rubin J, Dunning S, et al. Clinical and econom ic burden of community-acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc. 2012;60(11):2137-43. (PMID: 23110409)
- 5. Özmen İ, Yıldırım E, Ogun H, Yakar Hİ, Törün T, Çalışır H. Is the course of pneumonia the same in elderly and older patıents?. Turkish Journal of Geriatrics 2016;19(4):203-210 (No PMID or DOI)
- 6. Arnold FW, Reyes Vega AM, Salunkhe V, et al. Old er Adults Hospitalized for Pneumonia in the United States: Incidence, Epidemiology, and Outcomes. J Am Geriatr Soc. 2020;68(5):1007-1014. (PMID: 31916246).
- 7. Yılmaz, HEB, Ünsal ZE, Habeşoğlu MA, Kara S, Şen N. Factors Affecting Mortality In Geriatric Patients Diagnosed With Community-Acquired Pneumo nia Treated In Intensive Care Units. Turkish Journal of Geriatrics. 2021; 24(2): 212-219 (DOI: 10.31086/ tjgeri.2021.217).
- 8. Çetin N, Arslan G, Eler BÇ. Factors afffecting the treatment success of patients followed in the inten sive care unit with community-acquired pneumonia. Eurasian J Pulmonol 2021;23:101-9. (DOI: 10.4103/ ejop.ejop_102_20).
- 9. Gümüş A, Çilli A, Çakın Ö, Karakurt Z, Ergan B, Ak soy E, Cengiz M. Factors Affecting Cost of Patients with Severe Community-Acquired Pneumonia in In tensive Care Unit. Turkish Thoracic Journal. 2019 Jul 30;20(4):216-223. (PMID: 31390327).
- 10. Kosar F, Alici DE, Hacibedel B, Arpınar Yigitbas B, Golabi P, Cuhadaroglu C. Burden of community-ac quired pneumonia in adults over 18 y of age. Hum Vaccin Immunother. 2017 Jul 3;13(7):1673-1680. (PMID: 28281915).
- 11. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseas es Society of America. Am J Respir Crit Care Med. 2019;200(7):e45-e67. (PMID: 31573350)
- 12. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-ac quired pneumonia. N Engl J Med. 1997;336(4):243- 50. (PMID: 8995086)
- 13. Abdullah Sayıner & Cenk Babayiğit (Ed.) Turkish Thoracic Society Diagnosis and Treatment Consen sus Report on Community-accuired Pneumonia in Adults, 2021. ISBN: 978-605-74980-6-9. page 2,7-9 [Internet]. Available from: https://toraks.org.tr/site/ community/downloads/lAnyiRwJoRE7AGFc. Ac cessed: 05.12.2021.
- 14. Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer. J Am Coll Cardiol. 2017;70(19):2411-20. (PMID: 29096812)
- 15. Karalezli, A., Hasanoğlu, H. C., Kaya, et al. Cut-off val ue of D-dimer in pulmonary thromboembolism and pneumonia. Turkish Journal of Medical Sciences, 2009;39(5):687-692. (DOI:10.3906/sag-0903-9)
- 16. Jolobe OM. Elevated D-dimer levels signify overlap between community-acquired pneumonia and pul monary embolism. Eur J Intern Med. 2013;24(2):e18. (PMID: 22917756)
- 17. Güneysel O, Pirmit S, Karakurt S. Plasma d-dimer lev els increase with the severity of community acquired pneumonia. Tuberk Toraks. 2004;52(4):341-7. (PMID: 15558356)
- 18. Cerda-Mancillas MC, Santiago-Germán D, An drade-Bravo B, et al. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia. Arch Med Res. 2020;(5):429-435. (PMID: 32402575)
- 19. Lim WS, van der Eerden MM, Laing R, et al. Defin ing community acquired pneumonia severity on pre sentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-82. (PMID: 12728155)
- 20. Rello J, Rodriguez A. Severity of illness assessment for managing community-acquired pneumonia. Intensive Care Med. 2007;33(12):2043-4. (PMID: 17938882)
- 21. Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol. 2000;22(4):401-4. (PMID: 10745020)
- 22. Zhang Y, Zhou Q, Zou Y, et al. Risk factors for pulmo nary embolism in patients preliminarily diagnosed with community-acquired pneumonia: a prospective cohort study. J Thromb Thrombolysis. 2016;41(4):619- 27. (PMID: 26370200)
- 23. Ateş H, Ateş İ, Bozkurt B, et al. What is the most reliable marker in the differential diagnosis of pul monary embolism and community-acquired pneu monia? Blood Coagul Fibrinolysis. 2016;27(3):252-8. (PMID: 26258679)
- 24. Varol, A., Kokturk, N., Kilic, H. et al. The role of quan titative D-dimer levels in the follow-up and differential diagnosis of pulmonary thromboembolism and community-acquired pneumonia. Turkish Journal of Medical Sciences, 2012;42(4), 639-647. (DOI: 10.3906/ sag-1011-9)
- 25. Snijders D, Schoorl M, Schoorl M, et al. D-dimer lev els in assessing severity and clinical outcome in pa tients with community-acquired pneumonia. A sec ondary analysis of a randomised clinical trial. Eur J Intern Med. 2012;23(5):436-41. (PMID: 22726372)
- 26. Elbi H, Bilge A, Dayangaç HA, Dikmen O. Predıctıng The 28-Day Mortalıty Rate In Elderly Patıents Wıth Communıty-Acquıred Pneumonıa: Evaluatıon Of 11 Rısk Predıctıon Scores. Turkish Journal of Geriatrics 2017;20 (4):254-263. (No PMID or DOI).
- 27. Nastasijević Borovac D, Radjenović Petković T, Pe jčić T, et al. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia. Med Glas (Zenica). 2014;11(1):37-43. (PMID: 24496339)
- 28. Sürme S, Balkan İİ, Bayramlar OF, et al. Independent prognostıc indicators in the elderly wıth pneumonıa: a sıngle-center prospectıve observatıonal study. Turk ish Journal of Geriatrics 2020; 23(3): 342-352. (DOI: 10.31086/tjgeri.2020.171)
- 29. Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28(2):346-51. (PMID: 16611653)
- 30. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27(6):1210-6. (PMID: 16510452)
- 31. Kara S, Akçay MŞ, Ekici Ünsal Z, Bozkurt Yılmaz HE, Habeşoğlu MA. Comparative analysis of the patients with community-acquired pneumonia (CAP) and health care-associated pneumonia (HCAP) requiring hospitalization. Tuberk Toraks. 2019 Jun;67(2):108- 115. (PMID: 31414641).
- 32. Nwose EU, Richards RS, Jelinek HF, et al. D-dimer identifies stages in the progression of diabetes mel litus from family history of diabetes to cardiovascular complications. Pathology. 2007;39(2):252-7. (PMID: 17454757.
APA | Bulut S, Çelik D, Karamanli H (2022). THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. , 262 - 273. 10.31086/tjgeri.2022.284 |
Chicago | Bulut Sertan,Çelik Deniz,Karamanli Harun THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. (2022): 262 - 273. 10.31086/tjgeri.2022.284 |
MLA | Bulut Sertan,Çelik Deniz,Karamanli Harun THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. , 2022, ss.262 - 273. 10.31086/tjgeri.2022.284 |
AMA | Bulut S,Çelik D,Karamanli H THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. . 2022; 262 - 273. 10.31086/tjgeri.2022.284 |
Vancouver | Bulut S,Çelik D,Karamanli H THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. . 2022; 262 - 273. 10.31086/tjgeri.2022.284 |
IEEE | Bulut S,Çelik D,Karamanli H "THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA." , ss.262 - 273, 2022. 10.31086/tjgeri.2022.284 |
ISNAD | Bulut, Sertan vd. "THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA". (2022), 262-273. https://doi.org/10.31086/tjgeri.2022.284 |
APA | Bulut S, Çelik D, Karamanli H (2022). THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Türk Geriatri Dergisi, 25(2), 262 - 273. 10.31086/tjgeri.2022.284 |
Chicago | Bulut Sertan,Çelik Deniz,Karamanli Harun THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Türk Geriatri Dergisi 25, no.2 (2022): 262 - 273. 10.31086/tjgeri.2022.284 |
MLA | Bulut Sertan,Çelik Deniz,Karamanli Harun THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Türk Geriatri Dergisi, vol.25, no.2, 2022, ss.262 - 273. 10.31086/tjgeri.2022.284 |
AMA | Bulut S,Çelik D,Karamanli H THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Türk Geriatri Dergisi. 2022; 25(2): 262 - 273. 10.31086/tjgeri.2022.284 |
Vancouver | Bulut S,Çelik D,Karamanli H THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA. Türk Geriatri Dergisi. 2022; 25(2): 262 - 273. 10.31086/tjgeri.2022.284 |
IEEE | Bulut S,Çelik D,Karamanli H "THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA." Türk Geriatri Dergisi, 25, ss.262 - 273, 2022. 10.31086/tjgeri.2022.284 |
ISNAD | Bulut, Sertan vd. "THE PROGNOSTIC AND DIAGNOSTIC VALUE OF PLASMA D-DIMER LEVELS IN ELDERLY PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA". Türk Geriatri Dergisi 25/2 (2022), 262-273. https://doi.org/10.31086/tjgeri.2022.284 |